FI922851A - Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi - Google Patents

Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi Download PDF

Info

Publication number
FI922851A
FI922851A FI922851A FI922851A FI922851A FI 922851 A FI922851 A FI 922851A FI 922851 A FI922851 A FI 922851A FI 922851 A FI922851 A FI 922851A FI 922851 A FI922851 A FI 922851A
Authority
FI
Finland
Prior art keywords
virus
bound
cells
fsme
antigens
Prior art date
Application number
FI922851A
Other languages
English (en)
Swedish (sv)
Other versions
FI98377C (fi
FI922851A0 (fi
FI98377B (fi
Inventor
Wolfgang Mundt
Noel Barrett
Friedrich Dorner
Johann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI922851A0 publication Critical patent/FI922851A0/fi
Publication of FI922851A publication Critical patent/FI922851A/fi
Application granted granted Critical
Publication of FI98377B publication Critical patent/FI98377B/fi
Publication of FI98377C publication Critical patent/FI98377C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00Microcarriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FI922851A 1989-12-22 1992-06-18 Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi FI98377C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT292889 1989-12-22
AT2928/89A AT393356B (de) 1989-12-22 1989-12-22 Verfahren zur herstellung von fsme-virus-antigen
PCT/AT1990/000128 WO1991009935A1 (de) 1989-12-22 1990-12-21 Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen
AT9000128 1990-12-21

Publications (4)

Publication Number Publication Date
FI922851A0 FI922851A0 (fi) 1992-06-18
FI922851A true FI922851A (fi) 1992-06-18
FI98377B FI98377B (fi) 1997-02-28
FI98377C FI98377C (fi) 1997-06-10

Family

ID=3542524

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922851A FI98377C (fi) 1989-12-22 1992-06-18 Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi

Country Status (16)

Country Link
EP (1) EP0506714B1 (fi)
JP (1) JP2633391B2 (fi)
AT (2) AT393356B (fi)
CA (1) CA2071954C (fi)
CZ (1) CZ281804B6 (fi)
DE (1) DE59007659D1 (fi)
DK (1) DK0506714T3 (fi)
ES (1) ES2067916T3 (fi)
FI (1) FI98377C (fi)
HR (1) HRP921354A2 (fi)
HU (1) HU213886B (fi)
NO (1) NO310305B1 (fi)
RU (1) RU2082757C1 (fi)
SK (1) SK659090A3 (fi)
WO (1) WO1991009935A1 (fi)
YU (1) YU242390A (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015231A2 (en) * 1994-11-10 1996-05-23 Immuno Aktiengesellschaft Method for producing biologicals in protein-free culture
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
EP0841942B2 (fr) * 1995-08-01 2007-12-12 Sanofi Pasteur Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
AU743546B2 (en) * 1998-10-05 2002-01-31 Research Foundation For Microbial Diseases Of Osaka University, The Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
DK2235197T3 (en) * 2007-12-27 2017-10-09 Baxalta GmbH Methods of cell culture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
SE445116B (sv) * 1979-09-12 1986-06-02 Pharmacia Fine Chemicals Ab Sett att odla celler pa mikroberare med fibronektinytskikt
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
SE8103138L (sv) * 1981-05-19 1982-11-20 Pharmacia Fine Chemicals Ab Mikroberare for odling av forankringsberoende celler
CA1206900A (en) * 1981-12-21 1986-07-02 Raymond L. Downs Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
DD274336A3 (de) * 1985-10-03 1989-12-20 Npo Biolar Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung

Also Published As

Publication number Publication date
DE59007659D1 (de) 1994-12-08
EP0506714A1 (de) 1992-10-07
AT393356B (de) 1991-10-10
HU9202009D0 (en) 1992-10-28
SK279236B6 (sk) 1998-08-05
WO1991009935A1 (de) 1991-07-11
HUT65410A (en) 1994-06-28
CZ281804B6 (cs) 1997-02-12
EP0506714B1 (de) 1994-11-02
FI98377C (fi) 1997-06-10
RU2082757C1 (ru) 1997-06-27
ATA292889A (de) 1991-03-15
NO922422D0 (no) 1992-06-19
FI922851A0 (fi) 1992-06-18
HRP921354A2 (en) 1996-02-29
NO310305B1 (no) 2001-06-18
SK659090A3 (en) 1998-08-05
CA2071954C (en) 1996-06-18
NO922422L (no) 1992-08-17
FI98377B (fi) 1997-02-28
JPH05502581A (ja) 1993-05-13
ATE113652T1 (de) 1994-11-15
CZ659090A3 (en) 1996-11-13
CA2071954A1 (en) 1991-06-23
HU213886B (en) 1997-11-28
JP2633391B2 (ja) 1997-07-23
ES2067916T3 (es) 1995-04-01
YU242390A (sh) 1993-05-28
DK0506714T3 (da) 1995-04-18

Similar Documents

Publication Publication Date Title
HK1019233A1 (en) Animal cells and processes for the replication of influenza viruses
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
SE8000243L (sv) Typ ii-interferon och medel innehallande detsamma
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
DE69626022T2 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
BR8405600A (pt) Processo para estabelecer uma cultura de crescimento em um vaso,vaso selado,conjunto para preparar uma cultura de crescimento de microorganismos e processo para secar por congelamento microorganismos e nutriente e para estabelecer uma cultura de crescimento em um vaso
ATE7855T1 (de) Herstellung von virusantigenen.
FI98377B (fi) Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi
DE3775321D1 (de) Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
IE47060B1 (en) Process for the cultivation of viruses
DK439086D0 (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
SU1109990A1 (ru) Способ выращивания вируса ящура
KR870009018A (ko) 단순 포진에 대한 왁진
CA2250714A1 (en) Animal cells and processes for the replication of influenza viruses
NL7709998A (en) Foetal canine lung diploid cell line - for virus cultures esp. for rabies vaccine prodn.
KR960006940A (ko) 동물세포 배양법을 이용한 뉴캣슬병 백신의 생산방법
TH162A (th) กรรมวิธีสำหรับเตรียมวัคซีนป้องกันโรคกลัวน้ำ

Legal Events

Date Code Title Description
BB Publication of examined application